"We have 13 doctors who all specialize in a different area of the eye. We have one of the best LASIK Surgeons in the Bay Area and three experienced Cataract Surgeons. In addition, we have 9 doctors who are fellowship-trained in either retina, cornea, glaucoma, uveitis, neuro-ophthalmology, LASIK and refractive surgery, and cataract surgery. With a full-service facility, we offer the state of the art ophthalmic diagnostic testing instruments. Also, prescribe eyeglasses and contact lens. We have an optical shop in our office. Experiencing an urgent eye care issue? We also offer same-day urgent care appointments."

During the past decade, Pacific Eye Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pacific Eye Associates" #1 sponsor was "Allergan" with 2 trials, followed by "Anne Fung MD" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "National Eye Institute (NEI)" with 1 trials sponsored and "Pacific Eye Associates" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Eye Associates" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Office of Dietary Supplements (ODS)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Eye Associates" are "Age-related Macular Degeneration" (3 trials), "Macular Degeneration" (2 trials), "Wet Macular Degeneration" (2 trials), "Cataract" (1 trials) and "Glaucoma, Open-Angle" (1 trials). Many other conditions were trialed in "Pacific Eye Associates" in a lesser frequency.

Most popular intervention types in "Pacific Eye Associates" are "Drug" (6 trials), "Other" (2 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "ranibizumab" (2 trials), "Abicipar Pegol" (1 trials), "Active Comparator: Timolol 0.5%" (1 trials), "Bimatoprost SR" (1 trials) and "DHA/EPA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Eye Associates" are 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pacific Eye Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Pacific Eye Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Eye Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".